Schering's COMMITMENT TO CARE





		Resources
			Schering's COMMITMENT TO CARE
			The Be In Charge™ Program
			Links & Support Groups

Dealing with any illness and its treatment can be expensive, so it is very important for patients to know their financial rights and options. Schering's COMMITMENT TO CARE is Schering Oncology/Biotech's drug reimbursement assistance program for all eligible patients taking either PEG-INTRON® (peginterferon alfa-2b) Powder for Injection therapy, REBETRON® Combination Therapy containing REBETOL® (Ribavirin, USP) Capsules and INTRON® A (Interferon alfa-2b, recombinant) Injection, or INTRON A (Interferon alfa-2b, recombinant) for Injection therapy, whether they enroll in The Be In Charge™ Program support program or not. Since its inception in September 1995, COMMITMENT TO CARE has helped over 36,000 patients by providing reimbursement assistance for their medication.

Contact Schering's COMMITMENT TO CARE program

Protecting your personal information is very important to Schering Hepatitis Innovations. Please review our Privacy Policy to learn more about what we will and won�t do with the information you provide.

See also:

To: Schering's COMMITMENT TO CARE

Please provide your full name (first and last) plus complete street address or e-mail.

First Name
Last Name
Address
City
State	ZIP
E-Mail
Phone